Patents by Inventor Motohiro Horiuchi

Motohiro Horiuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240227180
    Abstract: A robot system includes a robot, and an information processing portion. The information processing portion is configured to obtain a learned model by learning first force information about a force applied by a worker to a workpiece, first position information about a position of a first portion of the worker, and first workpiece information about a state of the workpiece, and control the robot on a basis of output data of the learned model.
    Type: Application
    Filed: October 18, 2023
    Publication date: July 11, 2024
    Inventors: AKIHIRO ODA, KAZUHIKO SHINAGAWA, YUICHIRO KUDO, MOTOHIRO HORIUCHI
  • Publication number: 20240131699
    Abstract: A robot system includes a robot, and an information processing portion. The information processing portion is configured to obtain a learned model by learning first force information about a force applied by a worker to a workpiece, first position information about a position of a first portion of the worker, and first workpiece information about a state of the workpiece, and control the robot on a basis of output data of the learned model.
    Type: Application
    Filed: October 17, 2023
    Publication date: April 25, 2024
    Inventors: AKIHIRO ODA, KAZUHIKO SHINAGAWA, YUICHIRO KUDO, MOTOHIRO HORIUCHI
  • Patent number: 7476545
    Abstract: The present invention provides a method of quickly and accurately detecting and/or assaying an antigen using fluorescence correlation spectroscopy (FCS), which involves a fluorescence-labeled antibody fragment and a non-fluorescence-labeled intact antibody that form a complex with the antigen. There is a significant difference in diffusion rate between the fluorescence-labeled antibody fragment not bonded to the antigen and the complex formed by the the fluorescence-labeled antibody fragment, the antigen, and the non-fluorescence-labeled intact antibody, and this diffusion rate can be determined using FCS. The antigen can be an antigenic protein, such as an abnormal prion or a harmful protein contained in a food material. According to this method, antigens over a wide scope can be assayed regardless of the shape or molecular weight.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: January 13, 2009
    Assignee: Japan Science and Technology Agency
    Inventors: Masataka Kinjo, Motohiro Horiuchi, Fumihiko Fujii, Hiroshi Sakata, Mamoru Tamura, Masayoshi Ueno, Takayuki Yanagiya
  • Publication number: 20070184484
    Abstract: A monoclonal antibody which recognizes abnormal type prion protein alone is disclosed. By the present invention, an anti-abnormal type prion monoclonal antibody whose corresponding antigen is an abnormal type prion protein, and which does not substantially react with normal type prion protein was first provided. Since the corresponding antigen of the monoclonal antibody according to the present invention is the naturally occurring abnormal type prion protein, measurement of the abnormal type prion protein may be attained with high sensitivity.
    Type: Application
    Filed: October 31, 2002
    Publication date: August 9, 2007
    Applicants: Obihiro University of Agriculture and Veterinary Medicine, Fujirebio Inc.
    Inventors: Morikazu Shinagawa, Motohiro Horiuchi, Atsushi Umetani
  • Publication number: 20070160585
    Abstract: It is intended to provide a drug which is efficacious in treating a prion disease and has a high safety. A remedy for a prion disease which contains a mesenchymal stem cell as the active ingredient and a method of producing the same. A remedy for a prion disease which contains a mesenchymal stem cell, in particular, a mesenchymal stem cell having an anti-prion antibody gene transferred thereinto as the active ingredient and a method of producing the same. These remedies can not only prevent the progress of a prion disease but also contribute to the recovery of nerve dysfunction caused by the disease.
    Type: Application
    Filed: March 30, 2005
    Publication date: July 12, 2007
    Inventors: Kei Fujinaga, Morikazu Shinagawa, Yoshiro Niitsu, Hirofumi Hamada, Motohiro Horiuchi, Osamu Honmou, Atsushi Umetani
  • Publication number: 20070154950
    Abstract: The present invention provides a method of quickly and accurately detecting and/or assaying an antigen using fluorescence correlation spectroscopy (FCS), which involves a fluorescence-labeled antibody fragment and a non-fluorescence-labeled intact antibody that form a complex with the antigen. There is a significant difference in diffusion rate between the fluorescence-labeled antibody fragment not bonded to the antigen and the complex formed by the the fluorescence-labeled antibody fragment, the antigen, and the non-fluorescence-labeled intact antibody, and this diffusion rate can be determined using FCS. The antigen can be an antigenic protein, such as an abnormal prion or a harmful protein contained in a food material. According to this method, antigens over a wide scope can be assayed regardless of the shape or molecular weight.
    Type: Application
    Filed: December 4, 2006
    Publication date: July 5, 2007
    Inventors: Masataka Kinjo, Motohiro Horiuchi, Fumihiko Fujii, Hiroshi Sakata, Mamoru Tamura, Masayoshi Ueno, Takayuki Yanagiya